FibroBiologics Inc. (NASDAQ: FBLG) Stock Information | RedChip

FibroBiologics Inc. (NASDAQ: FBLG)


$5.32
+0.3150 ( +6.30% ) 132.5K

FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.

Market Data


Open


$5.32

Previous close


$5.00

Volume


132.5K

Market cap


$189.67M

Day range


$4.93 - $5.42

52 week range


$3.90 - $55.00

SEC Fillings


Form Type Description Pages Date
ars Annual reports 1 Jul 08, 2024
def Proxies and info statements 5 Jul 08, 2024
pre Proxies and info statements 5 Jun 27, 2024
8-k 8K-related 15 Jun 27, 2024
10-q Quarterly Reports 61 May 14, 2024
8-k 8K-related 17 Apr 26, 2024
4 Insider transactions 1 Mar 08, 2024
3 Insider transactions 1 Mar 06, 2024
10-k Annual reports 83 Feb 29, 2024
8-k 8K-related 16 Feb 20, 2024

Latest News